Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees

Funding News

Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

  Print-friendly version

   Email this page

NINDS requests applications for collaborative research to explore new uses for existing radioligands. This request is made together with 3 other NIH components.

The purpose of this funding opportunity is to stimulate research collaborations between two or more laboratories or sites at different institutions to enhance the use of radiopharmaceuticals in positron emission tomography or single photon emission computed tomography (PET/SPECT).  PET/SPECT technology has been extremely useful in evaluating and characterizing brain and other organ systems, in furthering the understanding of disease processes, and in monitoring the effects of therapeutic interventions.  However, one of the biggest limitations of PET/SPECT is the general lack of availability of radiopharmaceutical/radioligand imaging agents.

Letters Of Intent Date:  December 28, 2007.
Application Receipt Date: January 28, 2008.

Potential applicants should contact Dr. Debra Babcock, Program Director, Systems and Cognitive Neuroscience Cluster, NINDS; telephone: 301-496-9964; email: db390r@nih.gov. For a more detailed description of this program announcement, visit http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-08-001.html.